Holen Sie sich die Stockscreener-App
18.79
0.79%
-0.15
Handel nachbörslich:
18.79
10 X Genomics Inc Aktie (TXG) Neueste Nachrichten
10X Genomics Stock Hits Day Low of $18.80 Amid Price Pressure - Markets Mojo
Cathie Wood’s ARK trims 10X Genomics stock, adds DraftKings - Investing.com
Level Four Advisory Services LLC Acquires New Position in 10x Genomics $TXG - MarketBeat
Smart Money: Can 10x Genomics Inc grow without dilutionWeekly Trend Summary & Breakout Confirmation Alerts - baoquankhu1.vn
Risk Report: Can 10x Genomics Inc grow without dilutionJuly 2025 Sentiment & High Return Trade Guides - baoquankhu1.vn
10x Genomics $TXG Shares Bought by JPMorgan Chase & Co. - MarketBeat
Citigroup Inc. Increases Holdings in 10x Genomics $TXG - MarketBeat
ARK Investment Cuts Stake in 10x Genomics - National Today
10x genomics CEO Saxonov sells $367,096 in shares - Investing.com UK
10x Genomics $TXG Shares Sold by ARK Investment Management LLC - MarketBeat
Amova Asset Management Americas Inc. Has $62.86 Million Stock Holdings in 10x Genomics $TXG - MarketBeat
Life Sciences Tools & Services Stocks Q4 In Review: 10x Genomics (NASDAQ:TXG) Vs Peers - Finviz
10x Genomics (TXG) CEO sells shares and makes stock gift - Stock Titan
10x Genomics $TXG Position Lifted by Vanguard Group Inc. - MarketBeat
10X Genomics Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
Breaking Down 10x Genomics: 11 Analysts Share Their Views - Sahm
Commit To Buy 10x Genomics At $15, Earn 20.6% Annualized Using Options - Nasdaq
TXG Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
10x Genomics, Inc. (TXG) Stock Analysis: A Closer Look at the Healthcare Innovator’s Growth Potential and Analyst Ratings - DirectorsTalk Interviews
Stifel Nicolaus Boosts 10x Genomics Price Target to $25 - National Today
Major RSU grant to 10x Genomics (TXG) CEO Serge Saxonov - Stock Titan
88,816 RSUs awarded to 10x Genomics (TXG) director Hindson - Stock Titan
10x Genomics (TXG) CFO granted 106,579 RSUs in new equity award - Stock Titan
TXG affiliate files Form 144: proposed Class A Common sale (NASDAQ: TXG) - Stock Titan
10X Genomics Hits Day High with Strong 12.56% Intraday Surge - Markets Mojo
10x Genomics (NASDAQ:TXG) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says - MarketBeat
Is It Time To Reassess 10x Genomics (TXG) After Its 1 Year Share Price Surge - Yahoo Finance
10x Genomics (NASDAQ:TXG) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Is 10x Genomics Inc.’s ROIC above industry averageTrade Performance Summary & AI Driven Price Forecasts - mfd.ru
Insider Sell: Sarah Teichmann Sells Shares of 10x Genomics Inc (TXG) - GuruFocus
Director at 10x Genomics (TXG) sells 7,579 shares under 10b5-1 plan - Stock Titan
Is It Time To Reassess 10x Genomics (TXG) After Its 105% One Year Surge - simplywall.st
10x Genomics (TXG) Price Target Increased by 10.28% to 20.33 - Nasdaq
10x Genomics (NASDAQ:TXG) CEO Serge Saxonov Sells 9,632 Shares of Stock - MarketBeat
10x Genomics (TXG) CEO sells 9,632 shares to cover RSU tax - Stock Titan
[Form 4] 10x Genomics, Inc. Insider Trading Activity - Stock Titan
10x Genomics (TXG) officer sells 7,826 shares to cover RSU tax - Stock Titan
10x Genomics, Inc. (TXG) Stock Analysis: Navigating Growth Potential In Health Information Services - DirectorsTalk Interviews
Vestmark Advisory Solutions Inc. Sells 340,854 Shares of 10x Genomics $TXG - MarketBeat
Insider sale filing for TXG (NASDAQ: TXG) lists 8,301 shares on 02/23/2026 - Stock Titan
TXG (NASDAQ: TXG) insider sale notice: 25,784 RSU shares listed for sale - Stock Titan
Issuer insider sale notice — 23,767 shares (NASDAQ: TXG) - Stock Titan
Is 10x Genomics Inc. (1KJ) stock positioned for secular growthRecession Risk & Expert Curated Trade Ideas - mfd.ru
TXG: UBS Raises Price Target for 10x Genomics to $20 | TXG Stock News - GuruFocus
10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference - BioSpace
5 Must-Read Analyst Questions From 10x Genomics's Q4 Earnings Call - Finviz
GSA Capital Partners LLP Buys 106,167 Shares of 10x Genomics $TXG - MarketBeat
162,202 Shares in 10x Genomics $TXG Bought by Principal Financial Group Inc. - MarketBeat
10x Genomics Stock Climbs as Analysts Signal Growth Prospects - StocksToTrade
10x Genomics’ Growth Prospects Brightened by Strategic Advances - timothysykes.com
10x Genomics Cancer Alliances Test AI Ambitions Against Mixed Share Performance - Yahoo Finance
10x Genomics Sees Bullish Momentum Following Revenue Projections and Price Target Upgrades - StocksToTrade
10x Genomics Sees Bullish Momentum with Raised Price Targets - timothysykes.com
Is 10x Genomics Inc. still a buy after recent gains2025 Biggest Moves & AI Forecast Swing Trade Picks - mfd.ru
Decoding 10x Genomics Inc (TXG): A Strategic SWOT Insight - GuruFocus
Earnings Call Summary | 10x Genomics(TXG.US) Q4 2025 Earnings Conference - 富途牛牛
Expert Outlook: 10x Genomics Through The Eyes Of 10 Analysts - Benzinga
10X Genomics stock price target raised to $22 from $20 at Canaccord Genuity - Investing.com UK
Why Is 10x Genomics (TXG) Stock Soaring Today - Finviz
0.23%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):